FDA Guidance for Industry: Immunogenicity Assessment for Therapeutic Protein Products

Titel:
FDA Guidance for Industry: Immunogenicity Assessment for Therapeutic Protein Products
Herkunft/Verlag:

FDA, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM338856.pdf

Inhalt:
Bewertung immunologischer Nebenwirkung von therapeutischen Proteinen

Zurück

GMP Seminare nach Thema